Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples